News 2019

« BACK

Pharmacology



Results 21 - 40 of 43.


Health - Pharmacology - 27.06.2019
Interventions for Schistosomiasis Elimination in Zanzibar
Interventions for Schistosomiasis Elimination in Zanzibar
Schistosomiasis is a neglected tropical disease with a huge impact on global health. More than 200 million people are infected, mainly in sub-Saharan Africa. Researchers from Swiss TPH, the Natural History Museum London and partner institutions in Zanzibar have published a study on interventions for schistosomiasis elimination in Zanzibar, which found that while schistosomiasis was eliminated as a public health problem in over 90% of the study regions, transmission is not yet interrupted and reinfection occurs.

Health - Pharmacology - 27.06.2019
Hydrogel developed at EPFL offers real promise in treating diabetes
Hydrogel developed at EPFL offers real promise in treating diabetes
Researchers at EPFL have developed a hydrogel that offers unrivaled protection against transplanted cell rejection. The School's Technology Transfer Office has licensed the new product to Cell-Caps, a Geneva-based startup specialized in cell encapsulation for treating diabetes. Transplanted tissue often comes under attack from the body's immune system and struggles to survive in the hostile host environment.

Pharmacology - Life Sciences - 24.06.2019
New Therapy Promotes Vascular Repair Following Stroke
New Therapy Promotes Vascular Repair Following Stroke
Following a stroke, antibodies that inhibit the signaling molecule Nogo-A can help repair blood vessels in the affected brain regions. This also promotes the regaining of motor functions, researchers at the University of Zurich have shown in a mouse model. The study opens up new avenues for treatment.

Pharmacology - Life Sciences - 17.06.2019
Preventing drugs from being transported
Certain membrane proteins specialise in transporting molecules out of cells - a problem for the efficacy of cancer medication and antibiotics. An international research team has investigated the transport mechanism of a bacterial membrane protein using an artificially produced antibody fragment. The transport proteins, called ABC exporters, are present, for instance, in the cell membranes of bacteria and in large quantities in cancer cells and are responsible for transporting small molecules out of the cells.

Pharmacology - Health - 14.06.2019
Compound with anti-aging effects passes human trial
Compound with anti-aging effects passes human trial
Urolithin A, a metabolite of biomolecules found in pomegranates and other fruits, could help slow certain aging processes. EPFL spin-off Amazentis, in conjunction with EPFL and the Swiss Institute of Bioinformatics, has published a paper Metabolism outlining the results of their clinical trial. It is a fact of life that skeletal muscles begin to lose strength and mass once a person reaches the age of 50.

Pharmacology - Chemistry - 11.06.2019
Learning from Nature's Bounty: New Libraries for Drug discovery
Learning from Nature’s Bounty: New Libraries for Drug discovery
Natural products, or their close derivatives, make some of our most potent medicines, among which macrocycles with their large carbon-rich ring systems are one class. The size and complexity of macrocycles has made it difficult to emulate and build on Nature's success in the laboratory.

Pharmacology - Health - 21.05.2019
Using 3D to test personalised treatments in five days
Using 3D to test personalised treatments in five days
UNIGE researchers have developed a cell co-culture platform that can reproduce a patient's tumour in 3D and test the best treatment combinations for its specific case in just five days. Why doesn't the same treatment work in the same way for every patient? How can a drug's performance be optimised without causing side effects due to an excessive dosage? In an attempt to answer these questions, researchers at the University of Geneva (UNIGE), Switzerland, have devised a cell co-culture platform that reproduces a patient's tumour structure in 3D.

Health - Pharmacology - 26.04.2019
Individual nutrition shows benefits in hospital patients
Individual nutrition shows benefits in hospital patients
Individualized nutrition not only causes hospital patients to consume more protein and calories, but also improves clinical treatment outcomes. This has been demonstrated in a study by researchers from the University of Basel and Aarau Cantonal Hospital in the journal The Lancet. People who struggle to eat and drink properly following an illness are at risk of consuming too little protein and energy.

Health - Pharmacology - 23.04.2019
Simple and Fast Method for Radiolabelling Antibodies against Breast Cancer
Simple and Fast Method for Radiolabelling Antibodies against Breast Cancer
Radioactive antibodies that target cancer cells are used for medical diagnostics with PET imaging or for targeted radioimmunotherapy. Researchers from the University of Zurich have created a new method for radiolabelling antibodies using UV light. In less than 15 minutes, the proteins are ready-to-use for cancer imaging or therapy.

Health - Pharmacology - 15.04.2019
Precise Decoding of Breast Cancer Cells Creates New Option for Treatment
Researchers at the University of Zurich and from IBM Research have investigated the varying composition of cancer and immune cells in over one hundred breast tumors. They've found that aggressive tumors are often dominated by a single type of tumor cell. If certain immune cells are present as well, an immune therapy could be successful for a specific group of breast cancer patients.

Health - Pharmacology - 11.04.2019
The way people walk says a lot about how healthy they are
The way people walk says a lot about how healthy they are
Gait characteristics are sometimes regarded as the sixth vital sign in humans. They serve as a valuable indicator of a person's health, particularly in older adults - so why not measure them? A team of EPFL researchers is taking part in a major European project to design a device that can assess a person's gait more accurately.

Innovation - Pharmacology - 02.04.2019
Nestlé Health Science set to use anti-aging compound
Amazentis, an EPFL spin-off based in Innovation Park, announced today that it is entering into a strategic partnership with Nestlé Health Science. The startup plans to develop products based on urolithin A, a promising anti-aging compound. The Fountain of Youth is still the stuff of legend, but the anti-aging compound urolithin A is now one step closer to the market.

Health - Pharmacology - 28.03.2019
Breast cancer: the promises of old recipes
Breast cancer: the promises of old recipes
Researchers from UNIGE and UNIL demonstrate the efficacy of a well-known antibiotic in treating a particularly fatal form of breast cancer, offering hope for targeted therapy. Of the three major subtypes of breast cancer, the «triple negative» is the most lethal: half of all breast cancer deaths are attributed to it, whereas it accounts for only about 15% of incidences of breast cancer.

Health - Pharmacology - 13.03.2019
Stress hormones promote breast cancer metastasis
It has long been thought that stress contributes to cancer progression. Scientists from the University of Basel and the University Hospital of Basel have deciphered the molecular mechanisms linking breast cancer metastasis with increased stress hormones. In addition, they found that synthetic derivatives of stress hormones, which are frequently used as anti-inflammatory in cancer therapy, decrease the efficacy of chemotherapy.

Health - Pharmacology - 04.03.2019
Novartis data confirm rapid response and high efficacy of Cosentyx in psoriasis patients for first time in China
Phase III study shows close to 9/10 patients who received Cosentyx 300mg achieved clear or almost clear skin during the first 16 weeks of treatment (87%), with rapid onset of relief seen as early as week 3   Results strengthen unique position of Cosentyx as a rapid and long-lasting complete treatment of psoriatic disease, with over 200,000 patients treated worldwide   Data is being presented at the 2019 American Academy of Dermatology (AAD) Annu

Health - Pharmacology - 08.02.2019
Drug-resistant tuberculosis: high mortality rate due to inaccurate tests
Drug-resistant tuberculosis: high mortality rate due to inaccurate tests
Inaccurate tests carried out on tuberculosis patients in developing countries often fail to reliably detect resistance to drugs, leading to incorrect treatment and a higher mortality rate. These are the results of study by an international group of researchers led by a team at the University of Bern published today.

Health - Pharmacology - 05.02.2019
Even psychological placebos have an effect
Even psychological placebos have an effect
Placebo effects do not only occur in medical treatment - placebos can also work when psychological effects are attributed to them. Psychologists from the University of Basel reported these findings in the journal Scientific Reports, based on three studies with over 400 participants. Psychotherapy and placebos are both psychological interventions that not only have comparable effects, but that are also based on very similar mechanisms.

Chemistry - Pharmacology - 01.02.2019
Intuition and failure are valuable ingredients in chemistry
Intuition and failure are valuable ingredients in chemistry
When researchers make a new discovery, they tend to only publish the results of their successful experiments. But just as informative are all the experiments that didn't work - the failed trials and incorrect hypotheses, which can offer important information. A team of EPFL chemists has developed a methodology for collecting those lessons and, crucially, sharing them with other researchers.

Health - Pharmacology - 25.01.2019
Promising results in the fight against Ebola
Promising results in the fight against Ebola
A Phase 1 clinical trial to test the safety of an antibody to use against Ebola outbreak has been successfully concluded by the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland (U.S.A.).

Health - Pharmacology - 14.01.2019
Conversion of breast cancer cells into fat cells impedes the formation of metastases
Conversion of breast cancer cells into fat cells impedes the formation of metastases
An innovative combination therapy can force malignant breast cancer cells to turn into fat cells. This can be used to prevent the formation of metastases in mice, as researchers at the University of Basel's Department of Biomedicine recently reported in the journal Cancer Cell. Tumor cells can adapt dynamically to changing conditions thanks to their ability to reactivate a cellular process that is central to embryonic development.